California is joining with a New Jersey company to buy a generic opioid overdose reversal drug By Adam Beam - Associated Press Shares
Officials stock up on overdose antidote naloxone after fentanyl-laced letters disrupt vote counting Associated Press Shares
HHS officials give live demo of how to use overdose-reversing Narcan By Tom Howell Jr. - The Washington Times Shares
Biden leans into overdose fight as 2024 rivals focus on scourge By Tom Howell Jr. - The Washington Times Shares
DEA chief: Fentanyl remains the top threat, but a worse synthetic drug could emerge By Tom Howell Jr. - The Washington Times Shares
San Francisco wants Narcan available at every pharmacy By Olga R. Rodriguez - Associated Press Shares
FDA approves over-the-counter Narcan; here’s what it means By Geoff Mulvihill - Associated Press Shares
FDA panel weighs moving opioid antidote over the counter By Matthew Perrone - Associated Press Shares
Experts urge better opioid rescue drug access to save lives By Geoff Mulvihill and Sharon Johnson - Associated Press Shares
WH under pressure to deal with fentanyl, overdose crisis as GOP takes over House By Tom Howell Jr. - The Washington Times Shares
Over-the-counter naloxone could be coming to pharmacies, FDA says as it mulls change By Brad Matthews - The Washington Times Shares
CDC issues first major update to opioid prescribing advice since 2016 By Tom Howell Jr. - The Washington Times Shares
Walmart settles opioid crisis claims in Florida, pays $215 million and provides overdose kits By Brad Matthews - The Washington Times Shares
US approves high-dose opioid reversal nasal spray from Hikma By LINDA A. JOHNSON - Associated Press Shares
